Pediatric Oncology

Top Story

Foundation provides awards to physician–scientists

July 30, 2016

The Doris Duke Charitable Foundation presented Clinical Scientist Development Awards to 17 junior physician–scientists.

The recipients are between 1 and 5 years into their first faculty appointments. The awards — which consist of $495,000 per year for 3 years — are designed to support recipients’ transition into independent clinical research careers.

In the Journals Plus

High-dose methotrexate improves outcomes in children with B-ALL

July 29, 2016
High-dose methotrexate appeared superior to Capizzi methotrexate without increasing toxicity in children and young adults with high-risk B-acute lymphoblastic leukemia…
At Issue

Checkpoint inhibitor therapy more economical, safe than CAR T cells in pediatric leukemia

July 28, 2016
Novel advances in the use of checkpoint inhibitors – such as an anti-PD1 or anti-PDL1 – to treat pediatric leukemia may result in the ability to eliminate…
In the Journals Plus

Opinions on prognosis often discordant between patients and their oncologists

July 27, 2016
Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a cross-sectional study published…
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Video
Meeting News Coverage

VIDEO: Merge of immunotherapy, genomics lead to personalized treatment

June 23, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »

Foundation provides awards to physician–scientists

July 30, 2016
The Doris Duke Charitable Foundation presented Clinical Scientist Development Awards to 17 junior physician–scientists. The recipients are…

In the Journals Plus

High-dose methotrexate improves outcomes in children with B-ALL

July 29, 2016
High-dose methotrexate appeared superior to Capizzi methotrexate without increasing toxicity in children and young adults with high-risk B-acute…

At Issue

Checkpoint inhibitor therapy more economical, safe than CAR T cells in pediatric leukemia

July 28, 2016
Novel advances in the use of checkpoint inhibitors – such as an anti-PD1 or anti-PDL1 – to treat pediatric leukemia may result in the…

In the Journals Plus

Opinions on prognosis often discordant between patients and their oncologists

July 27, 2016
Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a…

In the Journals Plus

Multiple mental health symptoms common in adolescent cancer survivors

July 27, 2016
Adolescent survivors of childhood cancers frequently experienced concurrent behavioral, emotional and social deficits, according to research…

In the Journals Plus

Second malignancies, death common among cancer survivors

July 25, 2016
Approximately one in 12 patients with a common primary tumor were diagnosed with a second primary malignancy between 1992 and 2008, according to…

In the Journals Plus

Delirium frequently underdiagnosed in patients with advanced cancers

July 25, 2016
Delirium occurs frequently but appears underdiagnosed in patients with advanced cancer who presented in the ED, according to the results of a…

Memorial Sloan Kettering society presents inaugural prize

July 23, 2016
Richard J. O’Reilly, MD, of Memorial Sloan Kettering Cancer Center has been named the inaugural recipient of The Society of Memorial Sloan…

In the Journals

Pediatric melanomas mimic benign skin lesions

July 20, 2016
Pediatric melanomas that mimicked benign lesions had certain risk factors, including a history of evolution, bleeding and ulceration, according to…

In the Journals

Epstein–Barr virus status affects GVHD risk after HSCT

July 19, 2016
Donor Epstein–Barr virus donor and recipient status significantly influenced risk for acute and chronic graft-versus-host disease among…

More Headlines »
morganatic-roan
morganatic-roan